Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas. - Wikidata - awgldk - TriplyDB

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

http://www.wikidata.org/entity/Q36915106

about

Brain tumors Imaging biomarkers in primary brain tumours.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Incorporating prognostic imaging biomarkers into clinical practice.Amino acid PET and MR perfusion imaging in brain tumours.Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity.Visual and semiquantitative 11C-methionine PET: An independent prognostic factor for survival of newly diagnosed and treatment naive gliomas.Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.

P2860

Q24605136-BD3E46ED-7C1E-4D29-9CED-8E277BC46C17 Q30880129-950A4FF8-50D4-460E-978B-6AD9BCFD8EB2 Q31016200-00260807-C90A-43A0-8D75-03DD462FC29A Q33578187-76BFCDD4-5B36-47C4-8F04-44ADB4384456 Q35679377-438FC51E-2F54-4921-8D39-6ABA7D90705F Q37193816-2EFDCF4F-2055-46BD-A1EC-7A85A09B6CC2 Q38691946-95519656-1740-4341-AA8F-5CFF7C97DB54 Q46440180-D089006D-D238-40AE-8A72-74C00518224F Q47583631-0DA6A6BA-A942-4162-841C-94C2F3D74CC9 Q48241629-B2B8E411-5A18-4335-BA50-71D31588A339 Q50907799-FC5AAECF-61D9-4FC1-96AA-C47199D2FBC6 Q55388033-F25BDB19-EAC1-4480-853A-485FB55D93D5

P2860

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

http://www.wikidata.org/entity/Q36915106

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

@en

type

label

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

@en

prefLabel

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

@en

P1433

Q36915106-F7C9368A-8E08-4477-B8DE-7B4013F0A568

P1476

Q36915106-F799536A-D048-44ED-8DD1-B0B90C592EEA

P2093

Q36915106-0471ABB0-38B0-459C-861A-0A1C08CDCCF2

Q36915106-A50A5C48-6F2D-4309-A903-5F6704AAD0BF

Q36915106-A6158418-1372-4B73-B79C-D6F7F2DB5B01

P2860

Q36915106-308F8B24-406B-4C6C-A9B4-0730E8D14F7A

Q36915106-376CC129-EF45-4470-BBCC-E6C388D2CC0E

Q36915106-4C77FDC6-101A-4E94-8123-F60A1D79D3FF

Q36915106-7C41C156-B562-4070-81A0-0CF8D6531B64

Q36915106-9A227B2E-3464-49F0-A90C-516760E68104

Q36915106-9A6F1C08-C2D7-4508-BFD3-5308077A6102

Q36915106-B637062E-A091-4B0D-9EC8-6CB840E17ED0

Q36915106-E380341F-B4B5-4572-8E52-E25012A4EC9C

Q36915106-E50189D9-C053-4D76-A4A5-8C7EFA08FCFC

P2888

Q36915106-663F2526-FB1B-458B-8BF3-1A28CE760CBD

P304

Q36915106-71F483AD-2021-49A5-B249-D1FA59B41506

P31

Q36915106-184471A6-6924-4F6F-8E3B-C91E79357F2B

P356

Q36915106-0F3316F4-13FE-4010-A7A1-3038F5516A8F

P433

Q36915106-D131BC4F-BC95-4CB6-A413-4037B0A2CC65

P478

Q36915106-77DEB586-21A0-42E3-87A0-036E008B9DC4

P577

Q36915106-44739525-963C-4FB4-AA85-921E9F50F383

P698

Q36915106-1728941B-7780-4F09-9211-7E780D33AD65

P356

S00259-007-0531-1

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

@en

P2093

Ribom D

http://www.w3.org/2001/XMLSchema#string

Smits A

http://www.w3.org/2001/XMLSchema#string

Westerberg E

http://www.w3.org/2001/XMLSchema#string

P2860

The WHO classification of tumors of the nervous system.

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.

Late cognitive and radiographic changes related to radiotherapy: initial prospective findings.

11C-methionine PET for differential diagnosis of low-grade gliomas.

Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma.

Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis.

Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients.

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

P2888

s00259-007-0531-1

P304

65-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-007-0531-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17710394

http://www.w3.org/2001/XMLSchema#string